Oncology

Latest News

Patient navigation | Image credit: AON
With Thyme Care Partnership, AON Achieves $6M in Savings in EOM’s First Performance Period

April 22nd 2025

Within 5 years, the risk of SCC in particular was heightened among patients with MMP. | Image credit: wavebreak3 - stock.adobe.com
Rare Autoimmune Disorder Linked With Increased Risk of Certain Skin Cancers

April 21st 2025

AI technology | Image: Adobe Stock
Tech Updates: McKesson Launches Precision Oncology Consortium; Financing for RISA Labs PA Platform

April 17th 2025

IVBM Atlanta | Image credit: AJMC
Making Novel Cancer Therapies Available Requires Choices Because Resources Are Limited

April 14th 2025

Businessman shows medical network wooden block for health, medicine, insurance, healthcare, care, concept. Medical technology services to solve public - ภัทรชัย รัตนชัยวงค์ - stock.adobe.com.jpeg
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer

April 9th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Dr Lucio Gordan Names His Most Exciting Development in Oncology in the Last Year
June 4th 2016

Dr Lucio Gordan Names His Most Exciting Development in Oncology in the Last Year

New immunotherapies and biologics that are changing the landscape when it comes to treating patients are the most exciting development in oncology in the last year, according to Lucio Gordan, MD, of Florida Cancer Specialists.
Site Logo
June 4th 2016

Promising Results With Combination Immunotherapies, but Biomarkers Elusive

Surabhi Dangi-Garimella, PhD
As immunotherapy continues to show promise in solid as well as liquid tumors, clinicians have been evaluating these agents in combination. During a session on the second day of the ongoing annual meeting of the American Society of Clinical Oncology, in Chicago, IL, the results from some of these trials were shared.
Site Logo
June 4th 2016

Lessons in Cancer Care From NICE and Health Canada at ASCO

Surabhi Dangi-Garimella, PhD
On the first day of the annual meeting of the American Society of Clinical Oncology, healthcare experts from the United States, Canada, and the United Kingdom, compared and contrasted the care models that are widely adopted in each nation.
Site Logo
June 3rd 2016

Study Associates High BMI With Risk of Aggressive Prostate Cancer

Surabhi Dangi-Garimella, PhD
A study presented at the ongoing European Obesity Summit has confirmed a correlation between the risk of developing high grade prostate cancer and high body mass index and waist circumference.
Dr Stephen Grubbs Explains How ASCO Is Modifying Its Value Framework
June 3rd 2016

Dr Stephen Grubbs Explains How ASCO Is Modifying Its Value Framework

More than 400 comments were sent in regarding the American Society of Clinical Oncology (ASCO)'s Value Framework, and they will be incorporated as the framework evolves, explained Stephen Grubbs, MD, vice president for clinical affairs at ASCO.
Dr Debra Patt Acknowledges Progress Made Against Cancer
June 3rd 2016

Dr Debra Patt Acknowledges Progress Made Against Cancer

One of the important findings from the American Society of Clinical Oncology’s report is that cancer mortality has gone down, said Debra Patt, MD, MPH, MBA, director of public policy at Texas Oncology.
Site Logo
June 2nd 2016

First Liquid Biopsy Companion Diagnostic, for Erlotinib, Approved by FDA

Surabhi Dangi-Garimella, PhD
The FDA has approved the first ever blood-based companion diagnostic test. The cobas EGFR Mutation Test v2 was developed by Roche for the drug erlotinib (Tarceva), which was developed by Astellas for the treatment of non-small cell lung cancer.
Site Logo
June 1st 2016

Myriad Acquires Maker of EndoPredict Breast Cancer Prognostic Test

Mary Caffrey
The acquisition lets Myriad acquire the maker of EndoPredict, which just received reimbursement status from Aetna and meets ASCO guidelines for payment by Medicare contractors.
Site Logo
June 1st 2016

DSH Hospitals More Prone to Readmissions Following Cancer Surgery

Surabhi Dangi-Garimella, PhD
Hospitals that serve the more vulnerable population perform worse with their readmission rate following cancer surgery, and the subsequent penalties that they face can further strain the hospital’s already burdened finances.
Site Logo
May 31st 2016

ASCO Releases an Updated Value Framework

Surabhi Dangi-Garimella, PhD
The American Society of Clinical Oncology (ASCO)’s Value in Cancer Care Task Force has published an updated value framework that can help clinicians and patients assess the relative value of cancer therapies that have been compared in clinical trials.
Site Logo
May 31st 2016

Combining IL-21 and Ipilimumab Resulted in a 5-Year Remission in Metastatic Melanoma

Surabhi Dangi-Garimella, PhD
A single-patient study at the Fred Hutchinson Cancer Research Center found that combining ipilimumab and interleukin-21 (IL-21) in metastatic melanoma eradicated the tumors and the patient remained disease-free 5 years post treatment.
Site Logo
May 29th 2016

Close to Half of US New Cancer Diagnoses, Half of Cancer Deaths Preventable

Jackie Syrop
A substantial amount of US cancer diagnoses and deaths are preventable through lifestyle modification, according to a new study in JAMA Oncology, and the authors recommend that primary prevention remain a priority for cancer control.
This Week in Managed Care: May 28, 2016
May 28th 2016

This Week in Managed Care: May 28, 2016

This week in managed care, the top stories included new guidelines for treating obesity, updated guidelines for heart failure, and a study shed light on a shift in payment for opioids.
Site Logo
May 27th 2016

5 Things to Look for at the Annual ASCO 2016 Meeting

Surabhi Dangi-Garimella, PhD
The patient will be the focus during the 2016 annual meeting of the American Society of Clinical Oncology (ASCO), Collective Wisdom: The Future of Patient-Centered Care and Research.
Dr Sophia Smith Discusses Attending to Patients' Psychosocial Needs
May 27th 2016

Dr Sophia Smith Discusses Attending to Patients' Psychosocial Needs

Having psychosocial support for patients with cancer, and for their family members, is critical, because patients often feel that their emotional needs are overlooked in busy clinics, said Sophia K. Smith, PhD, MSW, associate professor at the Duke School of Nursing.
Site Logo
May 26th 2016

BMS Piqued by ICER's HTA Report on New Myeloma Drugs, Publishes Response

Surabhi Dangi-Garimella, PhD
Bristol-Myers Squibb has challenged the recently released report by the Institute for Clinical and Economic Review that evaluates the clinical and cost effectiveness of newer treatments for multiple myeloma.
Site Logo
May 26th 2016

Lung Cancer Patients at High-Volume Centers Survive Longer

Surabhi Dangi-Garimella, PhD
A new study published in the Journal of the National Cancer Institute has established that institutional volume can significantly influence survival in lung cancer patients receiving chemoradiation.
Site Logo
May 25th 2016

Surgery in Advanced Pancreatic Cancer Can Improve Survival, Says Mayo Study

Surabhi Dangi-Garimella, PhD
Oncologists at the Mayo Clinic have developed a more aggressive approach to treating patients with pancreatic cancer-combining surgery, chemotherapy, and radiation, surgical oncologists have been successful in significantly improving survival in a small number of patients.
Site Logo
May 25th 2016

What We're Reading: Senior Citizens Getting Sicker and More Costly

AJMC Staff
What we're reading, May 25, 2016: Senior citizens are expected to be sicker and more costly than the previous generation; men with early-stage cancer are increasingly choosing to avoid treatment; and the FDA is looking at an implantable treatment for opioid addiction.
Site Logo
May 24th 2016

MSK Survey Indicates Misbelief Responsible for Dismal Cancer Trial Participation

Surabhi Dangi-Garimella, PhD
A survey conducted by MaPS/Millward Brown Analytics, on behalf of Memorial Sloan Kettering Cancer Center, has identified multiple concerns of American consumers with cancer clinical trial participation, which could be responsible for the dismal 4% national enrollment rate in clinical trials.
Site Logo
May 23rd 2016

Early Results of an Oral CDK4/6 Inhibitor, Abemaciclib, Prove Mixed

Surabhi Dangi-Garimella, PhD
A phase 1 study in 225 patients diagnosed with breast cancer, non-small cell lung cancer, glioblastoma, melanoma, or colorectal cancer has concluded that abemaciclib, a selective inhibitor of the cell cycle regulators CDK4/6, has single-agent activity in specific tumor types.
Site Logo
May 23rd 2016

Another Lawsuit Against Genentech Over Trastuzumab Drug Volume

Surabhi Dangi-Garimella, PhD
An Oklahoma-based non-profit hospital is the latest medical facility to sue pharmaceutical giant Genentech,accusing the company of shipping less than the labeled claim of the anticancer drug trastuzumab (Herceptin) in each multi-dose vial.
Site Logo
May 20th 2016

Being Overweight Could Protect Against Dying From CRC, Says Kaiser Study

Surabhi Dangi-Garimella, PhD
Men and women diagnosed with colorectal cancer who were class I obese had the lowest risk of dying due to their cancer, according to a new study published in JAMA Oncology.
Site Logo
May 20th 2016

ACLU Complaint Against Myriad Genetics Suggests Broader Campaign to Compel Data Sharing

Mary Caffrey
The sequence of events that led to Thursday's complaint points to a coordinated effort to challenge Myriad Genetics' long-held position that it does not share information on public databases.
Site Logo
May 20th 2016

Non-Invasive, Chip-Based Detection of Lung Cancer Could Soon Be a Reality

Surabhi Dangi-Garimella, PhD
A microchip sensor that can measure specific volatile compounds in the breath of those with lung cancer, is being developed by research groups in the United States and in Britain.
Site Logo
May 19th 2016

What We're Reading: Where Colon Cancer Strikes Affects Survival

AJMC Staff
Stories on the potential health savings if more people quit smoking, and Louisiana's failed attempt to put nursing homes in managed care.
Site Logo
May 18th 2016

Few Eligible Cancer Patients Received All Quality Measures That Improve Survival Rates

Laura Joszt, MA
Survival rates increase as more quality measures are incorporated into care, but only 13% of eligible patients with Stage IIIA non-small cell lung cancer actually receive all 4 measures.
Site Logo
May 17th 2016

Physical Activity Reduces Risk of 13 Types of Cancer

Brenna Diaz
High levels of physical activity are associated with lower rates of cancer, according to a new study published in JAMA Internal Medicine.
Site Logo
May 17th 2016

Breast Cancer Multigene Testing Trends and Impact on Chemotherapy Use

G. Thomas Ray, MBA Jeanne Mandelblatt, MD Laurel A. Habel, PhD Scott Ramsey, MD, PhD Lawrence H. Kushi, ScD Yan Li, MD Tracy A. Lieu, MD, MPH
A multigene test for breast cancer recurrence risk was used in a minority of eligible patients, yet was associated with a decrease in chemotherapy use.
Site Logo
May 16th 2016

ADHD Diagnosis May Actually Be a Rare Tumor, Say NIH Researchers

Surabhi Dangi-Garimella, PhD
A new study warns that symptoms associated with rare CNS tumors could lead to a misdiagnosis of attention deficit hyperactivity disorder among pediatric patients.
<1
...
99100101102103104105106107
...
184>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo